New York residents who suffer from type 1 or type 2 diabetes run the risk of developing chronic kidney disease. Doctors generally study the estimated glomerular filtration rate and the urinary albumin to creatinine ratio to identify diabetes sufferers with high risks of developing these conditions, but doctors have long known that these two biomarkers are not always able to identify at-risk patients and often fail to accurately predict the onset of kidney failure.